Stem Cell Research (Jul 2022)

Generation of an iPSC line (SCTCi014-A) and isogenic control line (SCTCi014-A-1) from an age-related macular degeneration patient carrying the variant c.355G>A in the CFI gene

  • Sarah de Jong,
  • Louet Koolen,
  • Irene Vázquez-Domínguez,
  • Anita de Breuk,
  • Silvia Albert,
  • Carel B. Hoyng,
  • Suresh Katti,
  • Anneke I. den Hollander,
  • Alejandro Garanto

Journal volume & issue
Vol. 62
p. 102797

Abstract

Read online

Age-related macular degeneration (AMD) is a common eye disease among the elderly in the Western world. AMD is a multifactorial disease, with a strong association with genetic variation in the complement system. One of the AMD-associated variants is the c.355G>A (p.Gly119Arg) variant in complement factor I (CFI), a central regulator of complement activation. Here, we report the generation of an iPSC line and its isogenic wildtype control derived from peripheral blood mononuclear cells of a male AMD-affected individual carrying the heterozygous variant c.355G>A (p.Gly119Arg). The line can be utilized to study the effects of this variant in disease-specific cell types.